Cigna Group — Director's Dealing 2020

Sep 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2020-09-25

Reporting Person: DeLaney William J III (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-25	Common Stock, $.01 Par Value	M	3844.0000	$126.3224	Acquired	16623.0000	Direct
2020-09-25	Common Stock, $.01 Par Value	M	3376.0000	$151.4786	Acquired	19999.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-25	Employee Stock Option (Right to Buy)	$151.4786	M	3376.0000	Disposed	2026-05-04	Common Stock, $.01 Par Value (3376.0000)	Direct
2020-09-25	Employee Stock Option (Right to Buy)	$126.3224	M	3844.0000	Disposed	2027-05-11	Common Stock, $.01 Par Value (3844.0000)	Direct

Footnotes

F1: Transaction involved a cash exercise of an option to purchase shares of Cigna common stock. No shares of common stock were sold as part of this transaction.

F2: These stock options were granted on May 4, 2016 and vested in three equal installments beginning on May 1, 2017. All outstanding Express Scripts stock options vested and became exercisable upon the closing of the merger on December 20, 2018 under the terms of the Express Scripts Holding Company 2016 Long-Term Incentive Plan.

F3: These stock options were granted on May 11, 2017 and vested in three equal installments beginning on May 1, 2018. All outstanding Express Scripts stock options vested and became exercisable upon the closing of the merger on December 20, 2018 under the terms of the Express Scripts Holding Company 2016 Long-Term Incentive Plan.